Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
about
Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICAIntestinal nematode infection ameliorates experimental colitis in miceRole of the gut microbiota in defining human healthVirus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestineBlocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseA murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergenPurinergic Signaling in Gut Inflammation: The Role of Connexins and PannexinsIntegrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated CancerRole of regulatory T cell in the pathogenesis of inflammatory bowel diseaseA review on chemical-induced inflammatory bowel disease models in rodentsThe regulation of inflammation by interferons and their STATsGenetic update on inflammatory factors in ulcerative colitis: Review of the current literatureInnate and adaptive immunity in inflammatory bowel diseaseAssociation among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel diseaseImmunopathology of inflammatory bowel diseaseMolecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseasesOverview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseasesDysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel DiseaseChallenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel diseaseThe development and in vivo function of T helper 9 cellsInterleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implicationOsteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune responseCysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancerPreferential production of interferon-gamma by CD4+ T cells expressing the homing receptor integrin alpha4/beta7Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitisActivation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitisAnti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis ModelTherapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitisFood-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colonInflammatory bowel diseaseThe NLRP12 Sensor Negatively Regulates Autoinflammatory Disease by Modulating Interleukin-4 Production in T Cells.Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritisThe primary defect in experimental ileitis originates from a nonhematopoietic source.P-selectin and P-selectin glycoprotein ligand 1 are major determinants for Th1 cell recruitment to nonlymphoid effector sites in the intestinal lamina propria.The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitisElevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis.Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis.An antibiotic-responsive mouse model of fulminant ulcerative colitisGenetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.
P2860
Q24292262-0FF649A1-5FDF-4349-BDA1-6FE5CF852E78Q24537646-C6176758-F89D-4672-9F17-A7FEC51CEB41Q24599062-5FE5BC9A-6647-4846-B5F0-E03302F870F0Q24604466-99953303-1660-48D0-AC11-51B22D0BEF6EQ24610206-11DEAADC-FC2B-46C8-8496-DD3DAE534F06Q24680126-0D36BBD7-FA4A-4695-BDCD-3F4DC46631F8Q24805134-B0569072-40B6-4C3A-B2C0-9952CBFE413AQ26738433-1E6D2055-BD3B-4BEE-8030-662F42641896Q26764757-1EA09636-D3E6-441B-931C-6B266D3B9C3CQ26768560-7C13B3AD-8595-4CE5-933B-5767C8A3DE68Q26827500-2222E3A3-CE3B-409D-B6FE-E3D852FDAF6AQ26829387-F64685E0-C017-4793-9A2B-BB347937EE20Q26852514-3F1B58DF-03FA-48ED-9923-D57B0D4A345FQ26864276-22CEFE02-6762-4DD0-98DE-E871504F96F1Q27006589-2E79D77E-DB59-4A50-BDF6-AA708D7BCDD3Q27027636-D286FD5E-9EE8-4498-92B3-CD6FC705B6A0Q28067245-DC38F6BD-C348-4308-AA41-B2C5AF6286CBQ28069372-73C7C7FF-E591-44D1-99F9-A0AFA525FAE9Q28075218-E401BB80-E37A-46DF-857D-E3E4F9D97ABCQ28081921-32E8BB42-BF7F-4FDB-8CFA-B2F44EC69510Q28083375-03D13A52-B995-4E8E-AA56-93ED218E1C08Q28265856-070DCFBD-C028-4040-9A27-F585E7EF03C2Q28267161-6926F163-27C0-48DC-B1E1-2338D623C069Q28308101-94CCD884-B0BC-45E5-895B-F19514DB4CA8Q28367021-DF06D585-05AC-43D4-9344-4598A3E12742Q28472412-0AEB1B3F-8FF5-44A2-9BF0-C85361133E82Q28476563-B2BA34DB-ECF9-4B60-8C3C-9EAB8E9A2BE1Q28555141-B7669A09-C32F-459A-86A7-D7DAF2DC34DBQ28740568-3B3CB6FE-8D42-4185-AACA-336C6DDA744CQ29248437-363D548D-8365-45C9-9745-62A6945B14D4Q29615500-490314D0-61ED-4845-8343-675856A6A3B3Q30300172-FF86BCD5-3B0B-4166-A8B5-66880CD1EF68Q30434426-17158ED5-E0DD-4E65-945B-9644ADD113A2Q30439653-0C154AD1-7021-4E66-88B8-7A272FB5878EQ30442982-A3FD518B-BCBC-4E96-A14B-3E183F2CCA38Q30483252-769ED471-0556-4BB4-A445-776D94EED634Q30847621-A282A57C-A117-4D7A-80D7-47A8E9AECED2Q33264524-FCC35180-C3B1-44A0-872E-24F3C8C44B43Q33322360-3FEA7FDB-9CA7-4366-A723-97525935EB3DQ33507084-A1C841A3-35BD-46AF-84C5-655807CC1B01
P2860
Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Disparate CD4+ lamina propria ...... t increased secretion of IL-5.
@en
Disparate CD4+ lamina propria ...... t increased secretion of IL-5.
@nl
type
label
Disparate CD4+ lamina propria ...... t increased secretion of IL-5.
@en
Disparate CD4+ lamina propria ...... t increased secretion of IL-5.
@nl
prefLabel
Disparate CD4+ lamina propria ...... t increased secretion of IL-5.
@en
Disparate CD4+ lamina propria ...... t increased secretion of IL-5.
@nl
P2093
P1476
Disparate CD4+ lamina propria ...... st increased secretion of IL-5
@en
P2093
Boirivant M
de la Motte C
P304
P407
P577
1996-08-01T00:00:00Z